Literature DB >> 12014219

A case of neurotoxicity following 5-fluorouracil-based chemotherapy.

Seung Seog Ki1, Jin Mo Jeong, Seong Ho Kim, Sook Hyang Jeong, Jin Hyuk Lee, Chul Ju Han, You Cheol Kim, Jhin Oh Lee, Young Joon Hong.   

Abstract

5-Fluorouracil (5-FU) is a commonly used chemotherapeutic agent. However, its neurotoxicity is rare and not well recognized. We report a case of 5-FU neurotoxicity with organic brain syndrome and progression to multifocal leukoencephalopathy in a 44-year-old male patient having malignant gastrointestinal stromal tumor. 5-FU-induced neurotoxicity should, therefore, be considered as an important differential diagnosis in cancer patients with neurological abnormality and history of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014219      PMCID: PMC4531646          DOI: 10.3904/kjim.2002.17.1.73

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  19 in total

1.  Structural organization of the human dihydropyrimidine dehydrogenase gene.

Authors:  M R Johnson; K Wang; S Tillmanns; N Albin; R B Diasio
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  ACUTE CEREBELLAR SYNDROME SECONDARY TO 5-FLUOROURACIL THERAPY.

Authors:  J L RIEHL; W J BROWN
Journal:  Neurology       Date:  1964-10       Impact factor: 9.910

3.  Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity.

Authors:  M Tuchman; J S Stoeckeler; D T Kiang; R F O'Dea; M L Ramnaraine; B L Mirkin
Journal:  N Engl J Med       Date:  1985-07-25       Impact factor: 91.245

4.  Known variant DPYD alleles do not explain DPD deficiency in cancer patients.

Authors:  E S Collie-Duguid; M C Etienne; G Milano; H L McLeod
Journal:  Pharmacogenetics       Date:  2000-04

5.  Biochemical basis of the acute cerebellar syndrome in 5-fluorouracil chemotherapy.

Authors:  H Koenig; A Patel
Journal:  Trans Am Neurol Assoc       Date:  1969

Review 6.  Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.

Authors:  N Shehata; A Pater; S C Tang
Journal:  Cancer Invest       Date:  1999       Impact factor: 2.176

7.  Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs.

Authors:  R Okeda; T Karakama; S Kimura; S Toizumi; T Mitsushima; Y Yokoyama
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  "Organic brain syndrome" secondary to 5-fluorouracil toxicity.

Authors:  H T Lynch; C P Droszcz; W A Albano; J F Lynch
Journal:  Dis Colon Rectum       Date:  1981 Mar-Apr       Impact factor: 4.585

9.  Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.

Authors:  C H Takimoto; Z H Lu; R Zhang; M D Liang; L V Larson; L R Cantilena; J L Grem; C J Allegra; R B Diasio; E Chu
Journal:  Clin Cancer Res       Date:  1996-03       Impact factor: 12.531

10.  Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.

Authors:  G Milano; M C Etienne; V Pierrefite; M Barberi-Heyob; R Deporte-Fety; N Renée
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  4 in total

1.  Hyperammonemic encephalopathy associated with 5-fluorouracil in a patient with previous orthotopic liver transplantation.

Authors:  Hemnishil K Marella; Rahul Peravali; Amit L Jain; Satheesh Nair; Benedict Maliakkal; Uchenna Agbim; Rajanshu Verma
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-09

2.  5-Fluorouracil Neurotoxicity in the Absence of Dihydropyrimidine Dehydrogenase Deficiency Case Report.

Authors:  Rebecca Jules; Arushi Thaper; Ryan Foster; Pouya Ameli; Christopher Robinson; Michael Pizzi; Marc-Alain Babi; Carolina B Maciel; Katharina M Busl; Raju Reddy; William Roth
Journal:  Neurohospitalist       Date:  2022-01-03

3.  Neuropsychiatric Symptoms in a p16-Positive Tongue Carcinoma Patient: An Unexpected Diagnosis.

Authors:  Mohamed Iliyas Sultan Abdul Kader; Lee Suk Sian; Abd Razak Ahmad; Nurulwafa Hussain; Arnil George Sirimanne; Mohd Razif Mohamad Yunus
Journal:  Cureus       Date:  2022-08-22

4.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.